AstraZeneca Coronavirus Vaccine Candidate Shows Up to 90% Efficacy in Interim Analysis

AstraZeneca Coronavirus Vaccine Candidate Shows Up to 90% Efficacy in Interim Analysis·Motley Fool
In this article:

For the third time this month, a potential vaccine for the global scourge shows extremely strong results.

Advertisement